Want this question answered?
The amino acid sequence is shifted, and this kind of mutation is called a frame shift mutation. All of the amino acid sequence after the mutation will be changed, which will cause a change in shape of the protein, which will then probably result in a nonfunctional protein, since the shape of a protein determines its function.
yes but it would most likely be unnoticable
Missence mutation
a silent mutation.
phylogeny
The amino acid sequence is shifted, and this kind of mutation is called a frame shift mutation. All of the amino acid sequence after the mutation will be changed, which will cause a change in shape of the protein, which will then probably result in a nonfunctional protein, since the shape of a protein determines its function.
yes but it would most likely be unnoticable
When a mutation does not change the result of a normal production of a protein is called harmless. This is because it does no harm to the individual.
Missence mutation
A mutation in a DNA nucleotide sequence would be more harmful than a mutation in a mRNA nucleotide sequence because it could cause the synthesis of multiple nonfunctional proteins in comparison to a mutation in a mRNA nucleotide sequence that would be less harmful because it would result in a few nonfunctional proteins.
a silent mutation.
gene that codes for a specific protein
It is possible for a point mutation to not change the sequence of amino acids in a protein. This will result in the protein being unchanged and will not affect the phenotype.
A mutation in which an extra nitrogen base is added is called a frameshift mutation. The rest of the sequence after the mutation will code for different amino acids, which will result in the alteration of the protein. Frameshift mutations cause severe genetic disorders.
phylogeny
Nonfunctional zygote
An inactive/other active protein as a polypeptide that is incomplete will not fold properly. You could get a deleterious mutation that destroys protein product, such as Huntington's disease, or a paint mutation that, in heterozygous condition, such as sickle cell trait, is beneficial.